Citation Impact
Citing Papers
Regulatory T-cell directed therapies in liver diseases
2013 StandoutNobel
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Child abuse: Adolescent records vs. adult recall
1990 Standout
Expected characteristics of an ideal, all-purpose inhaled corticosteroid for the treatment of asthma
2003
Systemic and topical steroids in inflammatory bowel disease
2004
Modified‐release hydrocortisone for circadian therapy: a proof‐of‐principle study in dexamethasone‐suppressed normal volunteers
2007
Quantitative structure–pharmacokinetic/pharmacodynamic relationships
2006
The influence of drug-like concepts on decision-making in medicinal chemistry
2007 Standout
Inhaled Corticosteroids
2003
Fatal Autoimmune Hepatitis Induced by Concurrent Loss of Naturally Arising Regulatory T Cells and PD-1-Mediated Signaling
2008 StandoutNobel
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
2006 Standout
Herb-drug interactions
2000 Standout
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
Cushing's syndrome
2015 Standout
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
Cortisol Response to Operative Stress With Anesthesia in Healthy Children
2013
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Risk of Infectious Complications in Patients Taking Glucocorticosteroids
1989 Standout
Diagnosis and Management of Autoimmune Hepatitis
2010
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial
2000
Glucocorticosteroids Increase Cell Entry by Hepatitis C Virus
2010
Autoimmune Hepatitis, From Mechanisms to Therapy
2006
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
2016 Standout
NEWER DIAGNOSTIC TECHNIQUES AND PROBLEMS IN CUSHING'S DISEASE
1999
Review of the Molecular and Cellular Mechanisms of Action of Glucocorticoids for Use in Asthma
2002
Asthma
2017 Standout
Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis
1994
Acute Stressors and Cortisol Responses: A Theoretical Integration and Synthesis of Laboratory Research.
2004 Standout
Weight‐related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency
2004
Kinetics and Dynamics of Prednisolone*
1987
Pharmacokinetics and Pharmacodynamics of Systemically Administered Glucocorticoids
2005
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
Higher Cortisol Levels Following Exposure to Traumatic Reminders in Abuse-Related PTSD
2003
Glucocorticoids and immune function: physiological relevance and pathogenic potential of hormonal dysfunction
1995
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Inhaled and nasal corticosteroids Factors affecting the risks of systemic adverse effects
1999
Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis
2013 StandoutNobel
Use of nasal steroids in managing allergic rhinitis
1999
Systemic Adverse Effects of Inhaled Corticosteroid Therapy
1999
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
Triamcinolone Acetonide
1997
Intra‐articular depot formulation principles: Role in the management of postoperative pain and arthritic disorders
2008
Pharmacokinetic Optimisation of Antiemetic Therapy
1992
Magnetic nanoparticles in MR imaging and drug delivery
2008 Standout
Pharmacokinetics and systemic activity of fluticasone via Diskus® and pMDI, and of budesonide via Turbuhaler®
2001
Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis
1998
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease
2001
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Salivary cortisol in psychoneuroendocrine research: Recent developments and applications
1994 Standout
Intraarticular drug delivery in osteoarthritis☆
2006
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
Emotion regulation: Affective, cognitive, and social consequences
2002 Standout
Prolonged Anti-Inflammatory Action of DL-Lactide/Glycolide Copolymer Nanospheres Containing Betamethasone Sodium Phosphate for an Intra-Articular Delivery System in Antigen-Induced Arthritic Rabbit
2002
Stress-Induced Declarative Memory Impairment in Healthy Elderly Subjects: Relationship to Cortisol Reactivity1
1997
Pharmacokinetic and Adrenal Interactions of IL‐10 and Prednisone in Healthy Volunteers
1999
Intra-articular drug delivery systems: overcoming the shortcomings of joint disease therapy
2009
If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans.
2007 Standout
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease
2002 Standout
Salivary cortisol measurement in normal-weight, obese and anorexic women: comparison with plasma cortisol
2001
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
2008 Standout
Assessment of adrenal function in cirrhotic patients: Salivary cortisol should be preferred
2010
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Do Inhaled Corticosteroids Inhibit Growth in Children?
2001
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Intraarticular application of superparamagnetic nanoparticles and their uptake by synovial membrane—an experimental study in sheep
2005
Induction of Interleukin-4 and Interleukin-5 Expression in Mast Cells Is Inhibited by Glucocorticoids
1998
Iatrogenic Cushing’s Syndrome with Osteoporosis and Secondary Adrenal Failure in Human Immunodeficiency Virus-Infected Patients Receiving Inhaled Corticosteroids and Ritonavir-Boosted Protease Inhibitors: Six Cases
2005
Late-Night Salivary Cortisol as a Screening Test for Cushing’s Syndrome1
1998
Naming of substituted histamines
1974 StandoutNobel
Effect of Glycyrrhizin on the Pharmacokinetics of Prednisolone Following Low Dosage of Prednisolone Hemisuccinate.
1990
Diagnosis and Treatment of Hip and Knee Osteoarthritis
2021 Standout
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Cyclodextrin Drug Carrier Systems
1998 Standout
Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain
2018
Altered Responsiveness of the Hypothalamus-Pituitary-Adrenal Axis and the Sympathetic Adrenomedullary System to Stress in Patients with Atopic Dermatitis
2002
A Novel Family ofl -Amino Acid-Based Biodegradable Polymer−Lipid Conjugates for the Development of Long-Circulating Liposomes with Effective Drug-Targeting Capacity
2003
Mortality in Patients with Pituitary Disease
2010
The effect of SBE4-β-CD on i.m. prednisolone pharmacokinetics and tissue damage in rabbits: Comparison to a co-solvent solution and a water-soluble prodrug
1995
Are Intravenous Corticosteroids Required in Status Asthmaticus?
1988
How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions*
2000 Standout
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Computational Prediction of Oral Drug Absorption Based on Absorption Rate Constants in Humans
2006
Aspergillus fumigatusand Aspergillosis
1999 Standout
Intact and sympathectomized carotid bodies of long-term hypoxic rats: a morphometric ultrastructural study
1984
Use of Inhaled Corticosteroids and Risk of Fractures
2001 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
Non-surgical method for the induction of delayed implantation and recovery of viable blastocysts in rats and mice by the use of tamoxifen and Depo-Provera
1999 StandoutNobel
Nanomaterials in Plant Protection and Fertilization: Current State, Foreseen Applications, and Research Priorities
2012 Standout
The electron‐impact‐induced fragmentation of some methylated histamines
1972
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
2008 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management
2010
Works of H Möllmann being referenced
Pharmacokinetics of Rimexolone After Intra‐Articular Administration
1990
Dynamic Modeling of Cortisol Reduction after Inhaled Administration of Fluticasone Propionate
1996
Pharmacokinetic/Pharmacodynamic Evaluation of Systemic Effects of Flunisolide after Inhalation
1997
Simultaneous determination of glucocorticoid alcohols, their succinates and hydrocortisone in plasma
1985
Pharmacokinetic and Pharmacodynamic Evaluation of Triamcinolone Acetonide After Intravenous, Oral, and Inhaled Administration
1995
Budesonide in previously untreated autoimmune hepatitis
2005
Pharmacokinetic/Pharmacodynamic Aspects of Aerosol Therapy using Glucocorticoids as a Model
1997
Problematik des Äquivalenzbegriffes bei der Therapie mit Glucocorticoiden: Ein Vergleich der klinischen Pharmakokinetik und Pharmakodynamik von Prednisolon und Methylprednisolon
2008
Pharmacokinetics of Triamcinolone Acetonide After Intravenous, Oral, and Inhaled Administration
1995
Pharmacokinetics and Pharmacodynamics of Dexamethasone Sodium‐m‐Sulfobenzoate (DS) after Intravenous and Intramuscular Administration: A Comparison with Dexamethasone Phosphate (DP)
2001
Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration
1998
Pharmacokinetics and dose linearity testing of methylprednisolone phosphate
1989
Studies on the Pharmacokinetics and Metabolism of Prednicarbate after Cutaneous and Oral Administration
1993
A Pharmacokinetic/Pharmacodynamic Approach to Predict the Cumulative Cortisol Suppression of Inhaled Corticosteroids
1999
Dependency of Cortisol Suppression on the Administration Time of Inhaled Corticosteroids
1997
Pharmacokinetics and Oral Bioavailability of Hydrocortisone
1991
Pharmacokinetics of Methylprednisolone and Prednisolone After Single and Multiple Oral Administration
1997
Pharmacokinetic/Pharmacodynamic Evaluation of Deflazacort in Comparison to Methylprednisolone and Prednisolone
1995
HPLC determination of glucocorticoid alcohols, their phosphates and hydrocortisone in aqueous solutions and biological fluids
1986
Pharmacokinetics and Rectal Bioavailability of Hydrocortisone Acetate
1991
Comparative Pharmacokinetics of Methylprednisolone Phosphate and Hemisuccinate in High Doses
1988
EFFECT OF PROGESTERONE ON RNA AND PROTEIN SYNTHESIS IN THE RAT UTERUS
1973
Kinetics of methylprednisolone and its hemisuccinate ester
1985
The Biogenic Amines in the Carotid Body
1977
Pharmacokinetics and pharmacodynamics of prednisolone after intravenous and oral administration.
1992
Mechanism-based PK/PD model for the lymphocytopenia induced by endogenous and exogenous corticosteroids.
1999
Simultaneous Measurement of Cortisol in Serum and Saliva After Different Forms of Cortisol Administration
1992
Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration
1986
Pharmacokinetics of dexamethasone and its phosphate ester
1987
Pharmacokinetics of prednisolone after high doses of prednisolone hemisuccinate
1985
Mass spectra of derivatives of phenylalkylamines
1968
Pharmacokinetics and pharmacodynamics of inhaled corticosteroids
1998